drugset / Trial / NCT01118910

Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo

NCT01118910 ↗

Phase 0 Completed 15 enrolled Image Dermatology P.C.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if people with moist, red, patches on their skin in body folds would benefit treatment of those areas with an FDA-approved drug called Vusion.

Timeline

Start
2010-04
Primary completion
2010-11
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Vusion Unknown — Topical

Indications